Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Other Benefit Plans (Stock Option Activity) (Details)

v3.20.2
Stock-Based Compensation and Other Benefit Plans (Stock Option Activity) (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
$ / shares
shares
Jun. 30, 2020
USD ($)
$ / shares
shares
Stock-Based Compensation and Other Benefit Plans [Abstract]    
Number of Shares Underlying Options, Outstanding at January 1, 2020 | shares   2,834,000
Number of Shares Underlying Options, Granted | shares 644,758 644,000
Number of Shares Underlying Options, Unvested shares forfeited | shares   (60,000)
Number of Shares Underlying Options, Vested shares expired | shares   (132,000)
Number of Shares Underlying Options, Outstanding at March 31, 2020 | shares 3,286,000 3,286,000
Number of Shares Underlying Options, Exercisable at March 31, 2019 | shares 2,175,000 2,175,000
Weighted Average Exercise Price Per Share, Outstanding at January 1, 2020 | $ / shares   $ 1.55
Weighted Average Exercise Price Per Share, Granted | $ / shares $ 1.23 1.23
Weighted Average Exercise Price Per Share, Unvested shares forfeited | $ / shares   1.83
Weighted Average Exercise Price Per Share, Vested shares expired | $ / shares   4.71
Weighted Average Exercise Price Per Share, Outstanding at March 31, 2020 | $ / shares 1.35 1.35
Weighted Average Exercise Price Per Share, Exercisable at March 31, 2020 | $ / shares $ 1.27 $ 1.27
Weighted Average Remaining Contractual Term, Outstanding at March 31, 202-   3 years 4 months 24 days
Weighted Average Remaining Contractual Term, Exercisable at March 31, 2020   1 year 5 months 15 days
Aggregate Intrinsic Value, Outstanding at March 31, 2020 | $ $ 403 $ 403
Aggregate Intrinsic Value, Exercisable at March 31, 2020 | $ $ 345 $ 345